Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Nathan

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Microbiology Spectrum|February 25, 2017
Targeting Phenotypically Tolerant Mycobacterium tuberculosisBen Gold, Carl Nathan
Cell|March 23, 2010
SnapShot: Reactive Oxygen Intermediates (ROI)Carl Nathan, Aihao Ding
Immunological Reviews|February 24, 2015
Video podcast: TuberculosisCarl Nathan, Justina Stadanlick
Cold Spring Harbor Perspectives in Medicine|April 17, 2026
Cell-Autonomous Defense against TuberculosisCarl Nathan, John MacMicking
Molecular Medicine (Cambridge, Mass.)|June 25, 2002
Nonredundant antioxidant defense by multiple two-cysteine peroxiredoxins in human prostate cancer cellsChuanlu Shen, Carl Nathan
The Journal of Clinical Investigation|September 14, 2011
In vitro differentiation of human macrophages with enhanced antimycobacterial activityGuillaume Vogt, Carl Nathan
The New England Journal of Medicine|October 2, 2014
Antibiotic resistance--problems, progress, and prospectsCarl Nathan, Otto Cars
Cell|March 23, 2010
Nonresolving inflammationCarl Nathan, Aihao Ding
Nature Reviews. Immunology|April 27, 2013
Beyond oxidative stress: an immunologist's guide to reactive oxygen speciesCarl Nathan, Amy Cunningham-Bussel
Nature Reviews. Drug Discovery|October 26, 2005
Outlook: the profit problem in antibiotic R&DCarl Nathan, Frederick M Goldberg
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Microbiology Spectrum|February 25, 2017
Targeting Phenotypically Tolerant Mycobacterium tuberculosisBen Gold, Carl Nathan
Cell|March 23, 2010
SnapShot: Reactive Oxygen Intermediates (ROI)Carl Nathan, Aihao Ding
Immunological Reviews|February 24, 2015
Video podcast: TuberculosisCarl Nathan, Justina Stadanlick
Cold Spring Harbor Perspectives in Medicine|April 17, 2026
Cell-Autonomous Defense against TuberculosisCarl Nathan, John MacMicking
Molecular Medicine (Cambridge, Mass.)|June 25, 2002
Nonredundant antioxidant defense by multiple two-cysteine peroxiredoxins in human prostate cancer cellsChuanlu Shen, Carl Nathan
The Journal of Clinical Investigation|September 14, 2011
In vitro differentiation of human macrophages with enhanced antimycobacterial activityGuillaume Vogt, Carl Nathan
The New England Journal of Medicine|October 2, 2014
Antibiotic resistance--problems, progress, and prospectsCarl Nathan, Otto Cars
Cell|March 23, 2010
Nonresolving inflammationCarl Nathan, Aihao Ding
Nature Reviews. Immunology|April 27, 2013
Beyond oxidative stress: an immunologist's guide to reactive oxygen speciesCarl Nathan, Amy Cunningham-Bussel
Nature Reviews. Drug Discovery|October 26, 2005
Outlook: the profit problem in antibiotic R&DCarl Nathan, Frederick M Goldberg
Pageof 13